Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

When someone asks where you plan on traveling this year, odds are good Guatemala is not on the itinerary. But for nearly three decades, that’s exactly what two local doctors have been doing, ...

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

Shares of Merck & Co. Inc. MRK slid 1.81% to $88.05 Thursday, on what proved to be an all-around mixed trading session for ...